Mead Johnson Nutrition CO (NYSE:MJN) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Mead Johnson Nutrition CO achieved its new 52 week high price of $77.40 where it was opened at $74.20 UP +1.41 points or +1.94% by closing at $74.01.

Shares of Mead Johnson have been soaring higher today, along with the S&P 500, though for different reasons.

The United States Food & Drug Administration and the Centers for Disease Control announced this weekend that health inspectors have completed their testing on all formula samples collected from Mead Johnson and concluded that the Enfamil formula in question was safe.

The Associated Press reports a second baby is sick with Cronabacter after reportedly claiming the life of a Lebanon, Missouri newborn. That first newborn, 10-day-old Avery Cornett was preliminarily diagnosed with the rare bacteria after reportedly being fed with the Enfamil baby formula by Meade Johnson.